Table 3.
Antibody | Major central nervous system syndromes | Major associated neoplasms |
---|---|---|
Antibodies reacting with cytoplasmic and/or nuclear antigens | ||
Anti-Yo (PCA1) | Subacute cerebellar degeneration [Recently renamed “Rapidly progressive cerebellar syndrome” (9)] | Carcinoma of the ovary, uterus, or fallopian tube; carcinoma of the breast |
Anti-Hu (ANNA1) | Encephalomyelitis Subacute cerebellar degeneration Sensory neuronopathy Autonomic failure |
Small cell lung carcinoma (Myxoid chondrosarcoma) (Merkel cell and other neuroendocrine tumors) |
Anti-Ri (ANNA2) | Opsoclonus-ataxia syndrome Cerebella ataxia Encephalomyelitis |
Breast carcinoma Small cell lung cancer |
Anti-ANNA3 | Limbic encephalitis Encephalomyelitis Progressive cerebellar syndrome |
Small cell lung cancer |
Anti-CRMP5 | Encephalomyelitis Progressive cerebellar syndrome Chorea |
Small cell lung cancer Non-small cell lung cancer Thymoma |
Anti-Kelch-like protein 11 | Brainstem and cerebellar syndromes Cerebellar ataxia |
Ovarian, testicular, or other teratomas Seminomas |
Anti-Ma 1 & 2 | Limbic encephalitis, Brainstem encephalitis Progressive cerebellar syndrome |
Ma1: Small cell lung carcinoma Ma2: testicular seminoma |
Anti-SOX1 | Progressive cerebellar syndrome | Small cell lung cancer (Non-small cell lung cancer) |
Anti-Tra | Subacute cerebellar degeneration | Hodgkin's disease |
Antibodies reactive with intracellular synaptic or other | ||
membrane antigens | ||
Anti-Amphiphysin | Stiff person syndrome Limbic encephalitis |
Breast cancer Small cell lung cancer |
Anti-GAD65 | Stiff Person Spectrum Disorder Limbic Encephalitis Cerebellar ataxia |
Tumor association rare (Multiple tumor types reported in individual patients: breast, lung, thymoma, other) |
ANNA, antineuronal nuclear antibody; SCLC, small cell lung carcinoma; NSCLC, non- small-cell lung cancer; CRMP-5, collapsin response mediator protein 5; GAD, Glutamic acid decarboxylase; KLHL11, Kelch-like protein-11; PCA, Purkinje cell cytoplasmic antigen; DNER, delta/notch-like epidermal growth factor-related receptor.
Anti-Tr has been shown to react with glycosylated forms of the transmembrane delta/notch-like epidermal growth factor-related receptor (DNER). This protein is expressed intracellularly as well as at the neuronal cell membrane, and studies employing confocal and immune electron microscopy demonstrated anti-Tr immunolabelling of Purkinje cell cytosol, endoplasmic reticulum, dendrites as well as outer surface of the endoplasmic reticulum of neurons in the molecular layer (33, 34).